It is a pharma public limited company based in Gwalior, Madhya Pradesh, India, established in 1993.
1993 | Gwalior, Madhya Pradesh, India | ActiveCardinal Drug Limited, a active public limited company, was established on 14 January 1993 in Gwalior, Madhya Pradesh, India. Engaging in pharmaceutical retailers & distributors within the manufacturing sector, it holds CIN: U24114MP1993PLC007463. Registered under ROC Roc Gwalior. it is unlisted. It has an authorized capital of ₹6.60 Cr and a paid-up capital of ₹4.98 Cr.
Formerly known as Gwalior Fluorochem Limited, Gwalior Fluorochem Private Limited. It upholds a active non-compliant status. Its leadership includes Sunil Tarachand Kala (Director), Geetika Somani (Director), Anil Somani (Director). It holds ₹13.10 Cr open charges and ₹8.50 Cr settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at C/O Mercantile Agencies Jayendra Ganj, Gwalior, Madhya Pradesh, 474002.
U24114MP1993PLC007463
007463
14 January 1993
₹6.60 Cr
₹4.98 Cr
Roc Gwalior
Unlisted
Active
Explore comprehensive insights into Cardinal Drug Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sunil Tarachand Kala | Director | 01 Sep 1993 | Current |
| Geetika Somani | Director | 14 Jan 1993 | Current |
| Anil Somani | Director | 14 Jan 1993 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Cardinal Drug Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 175.3% increase. The company also saw a substantial fall in profitability, with a 878.48% decrease in profit. The company's net worth dipped by a decrease of 2.54%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Cardinal Drug had a promoter holding of 87.60% and a public holding of 12.40%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹131,000,000.00
₹85,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 01 May 1997 | State Bank Of India | ₹7.60 Cr | Open |
| 29 Jan 1997 | State Bank Of India | ₹4.60 Cr | Open |
| 08 Jan 1997 | M. P. Financial Corporation | ₹9.00 M | Open |
| 29 Oct 1996 | M. P. Financial Corporation | ₹9.00 M | Satisfied |
| 26 May 1995 | State Bank Of India | ₹7.60 Cr | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Cardinal Drug, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Cardinal Drug, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cardinal Drug's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Cardinal Drug Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was completed.
The activity Cardinal Drug Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Gwalior. was completed.
A charge registered on 26 May 1995 via Charge ID 90201624 with State Bank Of India was fully satisfied on 28 Jul 2006. was recorded as a recent event.
The activity A charge registered on 29 Oct 1996 via Charge ID 90210435 with M. P. Financial Corporation was fully satisfied on 26 May 2006. was completed.
A charge with M. P. Financial Corporation of Rs. 0.90 Cr registered on 29 Oct 1996 with Charge ID 90210435 was modified on 11 Aug 1997. was recorded as a recent event.
A charge with State Bank Of India of Rs. 7.60 Cr registered on 26 May 1995 with Charge ID 90201624 was modified on 11 Aug 1997. was recorded as a recent event.
The CIN of Cardinal Drug Limited is U24114MP1993PLC007463.
Cardinal Drug Limited is headquartered at C/O Mercantile Agencies Jayendra Ganj, Gwalior, Madhya Pradesh, 474002.
Cardinal Drug Limited was incorporated on 14 January 1993.
The current directors of Cardinal Drug Limited are
The primary industry of Cardinal Drug Limited is Manufacturing.
Cardinal Drug Limited is unlisted.
The authorized capital of Cardinal Drug Limited is ₹6.60 Cr, and the paid-up capital is ₹4.98 Cr.
The compliance status of Cardinal Drug Limited is Active Non-Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX